EXPRESSION OF MESSENGER-RNA FOR GM-CSF BY BLOOD MONONUCLEAR-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引:0
|
作者
ATKINSON, K [1 ]
ATTAVILLA, V [1 ]
COOLEY, M [1 ]
机构
[1] ST VINCENTS HOSP,DEPT HAEMATOL,SYDNEY,NSW 2010,AUSTRALIA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:506 / 506
页数:1
相关论文
共 50 条
  • [41] INVITRO PRIMING OF HUMAN BONE-MARROW WITH RECOMBINANT GM-CSF
    KORTHOUT, M
    LAN, J
    DEBOCK, R
    VANBOCKSTAELE, D
    PEETERMANS, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) : 376 - 377
  • [42] CONSTITUTIVE EXPRESSION OF GM-CSF MESSENGER-RNA BY CML BLAST CELLS IS CORRELATED WITH ENDOGENOUS MEGAKARYOCYTIC COLONY FORMATION
    LAJMANOVICH, A
    BERTHIER, R
    SCHWEITZER, A
    LEGER, J
    HOLLARD, D
    LEUKEMIA, 1993, 7 (08) : 1211 - 1218
  • [43] RAPID ANALYSIS OF TUMOR-NECROSIS-FACTOR-ALPHA MESSENGER-RNA EXPRESSION DURING VENOOCCLUSIVE DISEASE OF THE LIVER AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    TANAKA, J
    IMAMURA, M
    KASAI, M
    MASAUZI, N
    WATANABE, M
    MATSUURA, A
    MORII, K
    KIYAMA, Y
    NAOHARA, T
    HIGA, T
    HONKE, K
    GASA, S
    SAKURADA, K
    MIYAZAKI, T
    TRANSPLANTATION, 1993, 55 (02) : 430 - 432
  • [44] ACCELERATION OF BONE-MARROW ENGRAFTMENT BY RECOMBINANT DERIVED GM-CSF
    KRUMWIEH, D
    WAGNER, A
    REIFFERSCHEIDT, H
    SEILER, FR
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 123 - 123
  • [45] ACCURATE ENUMERATION OF CD34+ CELLS IN BONE-MARROW AND PERIPHERAL-BLOOD OF PATIENTS AFTER CHEMOTHERAPY AND GM-CSF
    SUTHERLAND, DR
    ANANIA, S
    NAYAR, R
    COLWILL, R
    STEWART, K
    SUTTON, D
    KEATING, A
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1163 - 1163
  • [46] MOUSE BONE-MARROW-DERIVED MAST-CELLS RELEASE IL-5 AND GM-CSF UPON IMMUNOLOGICAL STIMULATION IN AMOUNTS ABLE TO SUPPORT IN-VITRO EOSINOPHIL DIFFERENTIATION FROM BONE-MARROW PROGENITORS AND DISPLAY CONSTITUTIVE EXPRESSION OF IL-5 AND GM-CSF MESSENGER-RNA
    OSKERITZIAN, C
    MILON, G
    COLLE, JH
    MINOPRIO, P
    BRAQUET, P
    MENCIAHUERTA, JM
    DAVID, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 214 - 214
  • [47] HUMAN RECOMBINANT GM-CSF IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA - DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    POWLES, R
    SMITH, C
    MILAN, S
    TRELEAVEN, J
    MILLAR, J
    MCELWAIN, T
    GORDONSMITH, E
    MILLIKEN, S
    TILEY, C
    LANCET, 1990, 336 (8728): : 1417 - 1420
  • [48] CYTOCHEMICAL ANALYSIS OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - CORRELATION OF HYDROLASE EXPRESSION WITH GRAFT-VERSUS-HOST DISEASE
    REPETTO, M
    BACIGALUPO, A
    VIALE, M
    PIAGGIO, G
    GANDINI, M
    FRASSONI, F
    MARMONT, AM
    VANLINT, MT
    BLOOD, 1985, 66 (05) : 1011 - 1016
  • [49] LIGASE DETECTION REACTION PERMITS DETECTION AND SEMIQUANTITATION OF MULTIPLE ALTERNATIVELY SPLICED MESSENGER-RNA VARIANTS OF THE GM-CSF RECEPTOR ALPHA-SUBUNIT IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    ZUCKERMAN, KS
    HU, X
    BLOOD, 1993, 82 (10) : A237 - A237
  • [50] GM-CSF after allogeneic bone marrow transplantation for hematologic malignancies: 5-year follow-up.
    Mehta, J
    Powles, R
    Singhal, S
    Milan, S
    Treleaven, J
    BLOOD, 1995, 86 (10) : 1527 - 1527